- We expect VSDT to be a safe, meaning no Serious Adverse Events will take place during the study. - We expect the VSDT and EMDR conditions to reduce PTSD symptoms from pre to post measurement. - We expect the VSDT and EMDR conditions to reduce PTSD…
ID
Bron
Verkorte titel
Aandoening
Post-traumatic stress disorder (PTSD)
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
- PTSD symptoms (CAPS-5; PCL-5)
Achtergrond van het onderzoek
Background of the study:
Eye Movement Desensitization and Reprocessing (EMDR) is an evidence based therapy often indicated for patients suffering from post traumatic stress disorder (PTSD). A new therapy that shows resemblence with EMDR therapy is Visual Schema Displacement Therapy. Results from two recent studies among healthy participants comparing the two treatments showed that VSDT was more effective in reducing the emotional intensity of emotional memories. The question remains if and to what extent VSDT is effective in reducing PTSD symptoms in patients who are diagnosed with PTSD.
Objective of the study:
Determine if VSDT is effective in reducing PTSD symptoms, both directly and at 1- and 3-month follow-up. This will be investigated in a Randomized Controlled Trial (RCT).
Study design:
The study employs a mixed design with both within and between subjects factors. 57 PTSD patients will be randomly assigned to one of three conditions (EMDR, VSDT, waiting list). Both the VSDT and the EMDR condition include 6 sessions of 90 minutes each. PTSD symptoms will be monitored weekly using the Psychotrauma Checklist for DSM-5 (PCL-5), during and following the intervention until the last follow-up measurement after 3 months. A clinical interview for PTSD (Clinician-administered PTSD Scale for DSM-5; CAPS-5) will be conducted upon inclusion, after one month, and after three months after the treatment sessions.
Doel van het onderzoek
- We expect VSDT to be a safe, meaning no Serious Adverse Events will take place during the study.
- We expect the VSDT and EMDR conditions to reduce PTSD symptoms from pre to post measurement.
- We expect the VSDT and EMDR conditions to reduce PTSD symptoms from pre to follow-up 1 measurement.
- We expect the VSDT and EMDR conditions to reduce PTSD symptoms from pre to follow-up 2 measurement.
Onderzoeksopzet
CAPS-5: Pre, Follow-up 1 (4 weeks after treatment completion), Follow-up 2 (12 weeks after treatment completion).
Onderzoeksproduct en/of interventie
- Visual Schema Displacement Therapy
- Eye Movement Desensitization and Reprocessing
Algemeen / deelnemers
Wetenschappers
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
- IQ greater than 80 (estimation)
- PTSD diagnosis according to the DSM-5
- Age: 18 years and older
- Sufficient command of the Dutch language
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
- Acute suicidality
- PTSD is not the primary diagnosis
- Changes in medication 3 months prior or during the study.
- Use of sedating medication
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL7834 |
CCMO | NL68921.041.19 |
OMON | NL-OMON48388 |